
Nanolive SA is a Swiss company delivering breakthrough label-free live cell imaging and analysis solutions that accelerate research in drug discovery, cell therapy, and biotechnology. Their innovative platforms combine 3D live cell imaging with AI-powered digital assays to provide non-invasive, high-content, multiplexed data on living cells over unlimited time periods. Key products include the 3D Cell Explorer series and AI-driven assays like the Smart Mitochondrial AssayLIVE and LIVE T Cell Assay, enabling detailed insights into cell metabolism, immuno-oncology, and cytotoxicity. With over 300 units installed worldwide, patented technology, and a strong scientific foundation, Nanolive is positioned as a leader in live cell analysis for biotech and pharma markets.

Nanolive SA is a Swiss company delivering breakthrough label-free live cell imaging and analysis solutions that accelerate research in drug discovery, cell therapy, and biotechnology. Their innovative platforms combine 3D live cell imaging with AI-powered digital assays to provide non-invasive, high-content, multiplexed data on living cells over unlimited time periods. Key products include the 3D Cell Explorer series and AI-driven assays like the Smart Mitochondrial AssayLIVE and LIVE T Cell Assay, enabling detailed insights into cell metabolism, immuno-oncology, and cytotoxicity. With over 300 units installed worldwide, patented technology, and a strong scientific foundation, Nanolive is positioned as a leader in live cell analysis for biotech and pharma markets.
Headquarters: Tolochenaz, Vaud, Switzerland
Founded: 2013
Core product: Label-free tomographic 3D live-cell imaging (3D Cell Explorer family) with AI-driven digital assays
Installed base: Over 300 units
Recent financing: Series C / Series C-1 (initial close Apr 2022; Sep 20, 2022 listed)
Live-cell imaging and analysis for biomedical research, drug discovery, cell therapy, and biotechnology.
2013
Biotechnology Research
20000000
Initial closing of US$20 million reported on April 4, 2022; Series C listed on Sep 20, 2022 in company funding summaries.
“Participation from institutional investors including Taiwania Capital, Innoviva, and Swisscom Ventures”
Location: Tolochenaz, Switzerland
Terms: Full time (100%)
Start Date: Immediately
About us: Nanolive delivers breakthrough live cell imaging and analysis solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s imaging platforms combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.
This internship offers an excellent opportunity for a motivated and technically oriented individual with a strong interest in advanced instrumentation and customer support. As a Field Service Intern, you will assist in the installation, maintenance, and performance verification of Nanolive’s cutting-edge imaging platforms. Working closely with experienced service personal, you will gain hands-on experience in troubleshooting, system calibration, and customer interaction, contributing to the delivery of a high-quality user experience with Nanolive products.
Key Responsibilities
Installation and Support:
Reporting and Collaboration:
What We’re Looking For
What We Offer
| Company |
|---|